Unusual 11 Midday Movers 02/14: (KORS) (MDAS) (SYNM) Higher; (NAII) (ZIP) (MAS) Lower
Michael Kors Holdings (NYSE: KORS) 24.3% HIGHER; reported Q3 GAAP EPS of $0.20, pro-forma EPS of $0.28, vs. the analyst estimate of $0.08. Revenue for the quarter came in at $373.6 million versus the consensus estimate of $348.61 million. Sees Q4 2012 EPS of $0.10-$0.12, versus the consensus of $0.10. Sees Q4 2012 revenue of $350-$355 million, versus the consensus of $347.35 million. Sees FY2012 EPS of $0.74-$0.76, versus the consensus of $0.52. Sees FY2012 revenue of $1.27-$1.28 billion, versus the consensus of $1.25 billion.
MedAssets (Nasdaq: MDAS) 22.1% HIGHER; late yesterday reports suggested the company is considering leverage-buyout options.
Syntroleum (Nasdaq: SYNM) 19% HIGHER; Dynamic Fuels, LLC and Mansfield Oil Company have signed an agreement to supply renewable diesel to Norfolk Southern Corporation (NYSE: NSC). Dynamic is a 50/50 venture owned by Tyson (NYSE: TSN) and Syntroleum.
Natural Alternatives Internati (NASDAQ: NAII) 21.3% LOWER; reported Q2 EPS of $0.11, versus $0.12 reported last year. Revenue for the quarter came in at $16.2 million, versus $14.8 million reported last year.
LivePerson, Inc. (NASDAQ: LPSN) 18.8% HIGHER; reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $36.5 million versus the consensus estimate of $36.77 million. Sees Q1 adj-EPS of 8-10 cents on sales of $37-$37.5 million. The Street is currently expecting quarterly EPS of 9 cents on sales of $37.14 million. Sees FY12 adj-EPS of 40-44 cents on sales of $160-$165 million. Analysts looking for EPS of 42 cents on sales of $161.77 million.
Chelsea Therapeutics (Nasdaq: CHTP) 16.7% HIGHER; bouncing today following a nearly 40 percent decline yesterday amid news Dr. Simon Pedder plans to provide an update regarding the company's NDA forT NORHERA™ (droxidopa), an overview of key issues identified in the FDA briefing document received by the company and anticipated discussion points for the upcoming Cardiovascular and Renal Drugs Advisory Committee meeting scheduled for February 23rd.
Eagle Bulk Shipping (Nasdaq: EGLE) 16.6% HIGHER; continuing higher today as the drybulk sector is bouncing as the Dry Bulk Index is rebounding from 25-years low. Shares rose more than 11 percent yesterday.
Capella Education (NASDAQ: CPLA) 13.9% LOWER; reported Q4 EPS of $0.85, $0.06 worse than the analyst estimate of $0.91. Revenue for the quarter came in at $110 million versus the consensus estimate of $110.26 million. Capella University total active enrollment decreased 4.5 percent to 37,704 and new enrollment decreased by 9.4 percent from fourth quarter 2010. Sees Q112 revs falling by about 1 to 2 percent compared to first quarter 2011. Capella University total enrollment is expected to decline by about 5 to 6 percent compared to first quarter 2011.
Zipcar, Inc. (NASDAQ: ZIP) 13.5% LOWER; reported Q4 GAAP EPS of $0.09, $0.09 better than the analyst estimate of $0.00. Revenue for the quarter came in at $62.9 million versus the consensus estimate of $63.09 million. Total members grew 25% from the prior year period to more than 673,000 at quarter end. Sees FY2012 revenue of $290-$296 million, versus the consensus of $293.2 million.
Masco Corp. (NYSE: MAS) 13% LOWER; reported Q4 EPS of ($0.09), $0.04 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.78 billion.
Complete Genomics Inc. (Nasdaq: GNOM) 12.9% LOWER; investors are taking profits today after shares rose as high as 62% percent yesterday. The company announced it had been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
MedAssets (Nasdaq: MDAS) 22.1% HIGHER; late yesterday reports suggested the company is considering leverage-buyout options.
Syntroleum (Nasdaq: SYNM) 19% HIGHER; Dynamic Fuels, LLC and Mansfield Oil Company have signed an agreement to supply renewable diesel to Norfolk Southern Corporation (NYSE: NSC). Dynamic is a 50/50 venture owned by Tyson (NYSE: TSN) and Syntroleum.
Natural Alternatives Internati (NASDAQ: NAII) 21.3% LOWER; reported Q2 EPS of $0.11, versus $0.12 reported last year. Revenue for the quarter came in at $16.2 million, versus $14.8 million reported last year.
LivePerson, Inc. (NASDAQ: LPSN) 18.8% HIGHER; reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $36.5 million versus the consensus estimate of $36.77 million. Sees Q1 adj-EPS of 8-10 cents on sales of $37-$37.5 million. The Street is currently expecting quarterly EPS of 9 cents on sales of $37.14 million. Sees FY12 adj-EPS of 40-44 cents on sales of $160-$165 million. Analysts looking for EPS of 42 cents on sales of $161.77 million.
Chelsea Therapeutics (Nasdaq: CHTP) 16.7% HIGHER; bouncing today following a nearly 40 percent decline yesterday amid news Dr. Simon Pedder plans to provide an update regarding the company's NDA forT NORHERA™ (droxidopa), an overview of key issues identified in the FDA briefing document received by the company and anticipated discussion points for the upcoming Cardiovascular and Renal Drugs Advisory Committee meeting scheduled for February 23rd.
Eagle Bulk Shipping (Nasdaq: EGLE) 16.6% HIGHER; continuing higher today as the drybulk sector is bouncing as the Dry Bulk Index is rebounding from 25-years low. Shares rose more than 11 percent yesterday.
Capella Education (NASDAQ: CPLA) 13.9% LOWER; reported Q4 EPS of $0.85, $0.06 worse than the analyst estimate of $0.91. Revenue for the quarter came in at $110 million versus the consensus estimate of $110.26 million. Capella University total active enrollment decreased 4.5 percent to 37,704 and new enrollment decreased by 9.4 percent from fourth quarter 2010. Sees Q112 revs falling by about 1 to 2 percent compared to first quarter 2011. Capella University total enrollment is expected to decline by about 5 to 6 percent compared to first quarter 2011.
Zipcar, Inc. (NASDAQ: ZIP) 13.5% LOWER; reported Q4 GAAP EPS of $0.09, $0.09 better than the analyst estimate of $0.00. Revenue for the quarter came in at $62.9 million versus the consensus estimate of $63.09 million. Total members grew 25% from the prior year period to more than 673,000 at quarter end. Sees FY2012 revenue of $290-$296 million, versus the consensus of $293.2 million.
Masco Corp. (NYSE: MAS) 13% LOWER; reported Q4 EPS of ($0.09), $0.04 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $1.78 billion.
Complete Genomics Inc. (Nasdaq: GNOM) 12.9% LOWER; investors are taking profits today after shares rose as high as 62% percent yesterday. The company announced it had been selected by Mayo Clinic's Center for Individualized Medicine to provide outsourced whole human genome sequencing.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Unusual 11 Mid-Day Movers 05/25: (GNOM) (UPI) (RPRX) Higher; (TLB) (DCTH) (PAY) Lower
- Pre-Open Movers 5/24: (P) (HPQ) (PVH) Higher; (NTAP) (MTGE) (TIF) Lower (more...)
- Notable Analyst Rating Changes 05/25: (CRM) (EMN) (ITW) Upgraded; (HNZ) (COG) (LULU) Downgraded
Create E-mail Alert Related Categories
Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
